Presentations Image EN Corporate / 27.08.2026 IBA Half Year 2026 Results Presentation Read more IBA Half Year 2026 Results Presentation Financial results for 2025 Annual reports - all years Annual report 2025 IFRS consolidated results June 30 - all years Financial calendar & events Regulated Information Financial results press releases Our latest press releases View all press releases Subscribe to corporate press releases Regulated information Insider information Subscribe to IBA press releases distribution list Professional email First name Last name Phone number Company Country Choose a countryAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands I am an Investor Banker Media representative Financial analyst By submitting this form, I acknowledge that my information will be processed in accordance with IBA’s Privacy Policy. × Press releases Image EN FR RadioPharma Solutions / 01.10.2026 IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS® Read more IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS® Press releases Image EN FR Proton Therapy / 29.09.2026 Regulated information IBA signs contract to install the first proton therapy center in central Italy, in Rome Read more IBA signs contract to install the first proton therapy center in central Italy, in Rome Press releases Image EN FR Proton Therapy / 28.09.2026 Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide Read more Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide Business analyst coverage Frank Claassen Degroof Petercam Contact Michiel Declerq KBC Securities Contact David Vagman ING Contact Mathias Maenhaut Kepler Cheuvreux Contact Contact us A specific question ? We will be glad to help ! Your investor relations contact Thomas Pevenage - Investor Relations Tel: +32 10 47 58 90 Send us an email
Presentations Image EN Corporate / 27.08.2026 IBA Half Year 2026 Results Presentation Read more IBA Half Year 2026 Results Presentation
Press releases Image EN FR RadioPharma Solutions / 01.10.2026 IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS® Read more IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
Press releases Image EN FR Proton Therapy / 29.09.2026 Regulated information IBA signs contract to install the first proton therapy center in central Italy, in Rome Read more IBA signs contract to install the first proton therapy center in central Italy, in Rome
Press releases Image EN FR Proton Therapy / 28.09.2026 Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide Read more Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
